This page is part of the Quality Improvement Core Framework (v7.0.0: STU7 (v7.0.0)) based on FHIR (HL7® FHIR® Standard) R4. This is the current published version. For a full list of available versions, see the Directory of published versions
Page standards status: Informative |
Profile: QICore MedicationAdministration
status: Completed
medication: Medication alemtuzumab 10 MG/ML [Lemtrada]
subject: Donald Duck
supportingInformation: Condition Burn of ear
effective: 2015-01-15 14:30:00+0100 --> 2015-01-15 14:30:00+0100
Route | Dose |
Intravenous route (qualifier value) | 3 mg (Details: UCUM codemg = 'mg') |